{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:59:52Z","timestamp":1785113992536,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,26]]},"DOI":"10.7759\/cureus.113417","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:18:57Z","timestamp":1785111537000},"source":"Crossref","is-referenced-by-count":0,"title":["In-Hospital Complications of Acute Decompensated Heart Failure Patients With Comorbid Rheumatoid Arthritis: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Javier","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataraghavan","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshul","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muni","family":"Rubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25481","article-title":"Risk of incident heart failure and heart failure subtypes in patients with rheumatoid arthritis","volume":"77","author":"Kawano Y","year":"2025","unstructured":"Kawano Y, Weber BN, Weisenfeld D, et al.. Risk of incident heart failure and heart failure subtypes in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2025, 77:631-9. 10.1002\/acr.25481","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid\u00a0arthritis\u00a0and risk of ischemic\u00a0and nonischemic heart failure","volume":"69","author":"Mantel \u00c4","year":"2017","unstructured":"Mantel \u00c4, Holmqvist M, Andersson DC, Lund LH, Askling J. Association between rheumatoid\u00a0arthritis\u00a0and risk of ischemic\u00a0and nonischemic heart failure. J Am Coll Cardiol. 2017, 69:1275-85. 10.1016\/j.jacc.2016.12.033","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24804","article-title":"Association between inflammation, incident heart failure, and heart failure subtypes in patients with rheumatoid arthritis","volume":"75","author":"Huang S","year":"2023","unstructured":"Huang S, Cai T, Weber BN, et al.. Association between inflammation, incident heart failure, and heart failure subtypes in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2023, 75:1036-45. 10.1002\/acr.24804","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-026-06101-8","article-title":"Heart failure in autoimmune rheumatic diseases","volume":"46","author":"Fedorchenko Y","year":"2026","unstructured":"Fedorchenko Y, Zimba O, Fedorchenko M, Permenov BA, Kocyigit BF. Heart failure in autoimmune rheumatic diseases. Rheumatol Int. 2026, 46:2026. 10.1007\/s00296-026-06101-8","journal-title":"Rheumatol Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.37349\/ec.2026.101284","article-title":"Long-term cardiovascular sequelae of COVID-19 in patients with pre-existing heart failure: a systematic review","volume":"4","author":"Parizad R","year":"2026","unstructured":"Parizad R, Hatwal J, Brar A, Batta A, Sadeghi MT, Mohan B. Long-term cardiovascular sequelae of COVID-19 in patients with pre-existing heart failure: a systematic review. Exploration of Cardiology. 2026, 4:101284. 10.37349\/ec.2026.101284","journal-title":"Exploration of Cardiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2025.09.008","article-title":"Decoding long COVID-associated cardiovascular dysfunction: mechanisms, models, and new approach methodologies","volume":"209","author":"Thomas D","year":"2025","unstructured":"Thomas D, Yang PC, Wu JC, Sayed N. Decoding long COVID-associated cardiovascular dysfunction: mechanisms, models, and new approach methodologies. J Mol Cell Cardiol. 2025, 209:37-50. 10.1016\/j.yjmcc.2025.09.008","journal-title":"J Mol Cell Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.41979","article-title":"Myocardial dysfunction and heart failure in rheumatoid arthritis","volume":"74","author":"Park E","year":"2022","unstructured":"Park E, Griffin J, Bathon JM. Myocardial dysfunction and heart failure in rheumatoid arthritis. Arthritis Rheumatol. 2022, 74:184-99. 10.1002\/art.41979","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad056","article-title":"Mortality in heart failure with and without autoimmune disease","volume":"30","author":"Sun G","year":"2023","unstructured":"Sun G, Faurschou M, Vinding NE, et al.. Mortality in heart failure with and without autoimmune disease. Eur J Prev Cardiol. 2023, 30:1308-14. 10.1093\/eurjpc\/zwad056","journal-title":"Eur J Prev Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.04.016","article-title":"Autoimmune disorders in heart\u00a0failure with preserved ejection fraction","volume":"12","author":"Tada A","year":"2024","unstructured":"Tada A, Doi S, Harada T, et al.. Autoimmune disorders in heart\u00a0failure with preserved ejection fraction. JACC Heart Fail. 2024, 12:1257-69. 10.1016\/j.jchf.2024.04.016","journal-title":"JACC Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152727","article-title":"Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure","volume":"73","author":"Chandrupatla SR","year":"2025","unstructured":"Chandrupatla SR, Singh JA. Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure. Semin Arthritis Rheum. 2025, 73:152727. 10.1016\/j.semarthrit.2025.152727","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-025-02740-2","article-title":"Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction","author":"Goertz M","year":"2025","unstructured":"Goertz M, Schupp T, Dudda J, et al.. Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction. Clin Res Cardiol. 2025, 10.1007\/s00392-025-02740-2","journal-title":"Clin Res Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.11.771","article-title":"Extra-articular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events","volume":"52","author":"Voskuyl AE","year":"1993","unstructured":"Voskuyl AE, Van de Laar MA, Moens HJ, Van der Korst JK. Extra-articular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events. Ann Rheum Dis. 1993, 52:771-5. 10.1136\/ard.52.11.771","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1157-0","article-title":"Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis","volume":"18","author":"Verhoeven F","year":"2016","unstructured":"Verhoeven F, Prati C, Maguin-Gat\u00e9 K, Wendling D, Demougeot C. Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis. Arthritis Res Ther. 2016, 18:258. 10.1186\/s13075-016-1157-0","journal-title":"Arthritis Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13901","article-title":"The role of platelet-neutrophil interactions in driving autoimmune diseases","volume":"175","author":"Liu Q","year":"2025","unstructured":"Liu Q, Zhu W, Wen X, Da Y. The role of platelet-neutrophil interactions in driving autoimmune diseases. Immunology. 2025, 175:1-15. 10.1111\/imm.13901","journal-title":"Immunology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014661","article-title":"Heart failure risk associated with rheumatoid arthritis-related chronic inflammation","volume":"9","author":"Ahlers MJ","year":"2020","unstructured":"Ahlers MJ, Lowery BD, Farber-Eger E, et al.. Heart failure risk associated with rheumatoid arthritis-related chronic inflammation. J Am Heart Assoc. 2020, 9:e014661. 10.1161\/JAHA.119.014661","journal-title":"J Am Heart Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese EM","year":"2023","unstructured":"Gravallese EM, Firestein GS. Rheumatoid arthritis - common origins, divergent mechanisms. N Engl J Med. 2023, 388:529-42. 10.1056\/NEJMra2103726","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta JA","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012, 71:1524-9. 10.1136\/annrheumdis-2011-200726","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby P","year":"2008","unstructured":"Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med. 2008, 121:S21-31. 10.1016\/j.amjmed.2008.06.014","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.15212\/CVIA.2026.0001","article-title":"Emerging novel biomarkers in acute coronary syndrome management: insights and future directions","volume":"11","author":"Mittal A","year":"2026","unstructured":"Mittal A, Singhal K, Djoumsie EB, Sharma YP, Batta A. Emerging novel biomarkers in acute coronary syndrome management: insights and future directions. CVIA. 2026, 11:984.","journal-title":"CVIA"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised trial","volume":"400","author":"Mebazaa A","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O, et al.. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised trial. Lancet. 2022, 400:1938-1952.","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.02.001","article-title":"Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction","volume":"259","author":"Fax\u00e9n J","year":"2023","unstructured":"Fax\u00e9n J, Benson L, Mantel \u00c4, et al.. Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction. Am Heart J. 2023, 259:42-51. 10.1016\/j.ahj.2023.02.001","journal-title":"Am Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105122","article-title":"Risk of venous thromboembolism in rheumatoid arthritis","volume":"88","author":"Ketfi C","year":"2021","unstructured":"Ketfi C, Boutigny A, Mohamedi N, Bouajil S, Magnan B, Amah G, Dillinger JG. Risk of venous thromboembolism in rheumatoid arthritis. Joint Bone Spine. 2021, 88:105122. 10.1016\/j.jbspin.2020.105122","journal-title":"Joint Bone Spine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202111_27249","article-title":"Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis","volume":"25","author":"Hu LJ","year":"2021","unstructured":"Hu LJ, Ji B, Fan HX. Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis. Eur Rev Med Pharmacol Sci. 2021, 25:7005-13. 10.26355\/eurrev_202111_27249","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.07.006","article-title":"Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population","volume":"50","author":"Myasoedova E","year":"2020","unstructured":"Myasoedova E, Davis JM 3rd, Matteson EL, et al.. Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population. Semin Arthritis Rheum. 2020, 50:25-9. 10.1016\/j.semarthrit.2019.07.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25541","article-title":"Avoidable hospitalizations in persons with rheumatoid arthritis: a population-based study using administrative data","volume":"77","author":"Contreras DG","year":"2025","unstructured":"Contreras DG, Barber CE, Avi\u00f1a-Zubieta JA, Quan H, Lee S, King JA, Barnabe C. Avoidable hospitalizations in persons with rheumatoid arthritis: a population-based study using administrative data. Arthritis Care Res (Hoboken). 2025, 77:1014-21. 10.1002\/acr.25541","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200265","article-title":"The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"48","author":"Ozen G","year":"2021","unstructured":"Ozen G, Pedro S, Michaud K. The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 2021, 48:648-55. 10.3899\/jrheum.200265","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23875","article-title":"Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"72","author":"Singh S","year":"2020","unstructured":"Singh S, Fumery M, Singh AG, et al.. Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2020, 72:561-76. 10.1002\/acr.23875","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024579","article-title":"Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: an updated meta-analysis","volume":"100","author":"Sun KJ","year":"2021","unstructured":"Sun KJ, Liu LL, Hu JH, Chen YY, Xu DY. Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: an updated meta-analysis. Medicine (Baltimore). 2021, 100:e24579. 10.1097\/MD.0000000000024579","journal-title":"Medicine (Baltimore)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha R","year":"2011","unstructured":"Micha R, Imamura F, Wyler von Ballmoos M, Solomon DH, Hern\u00e1n MA, Ridker PM, Mozaffarian D. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol. 2011, 108:1362-70. 10.1016\/j.amjcard.2011.06.054","journal-title":"Am J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S523939","article-title":"The effects of disease-modifying antirheumatic drugs on cardiovascular risk in inflammatory joint diseases: current evidence and uncertainties","volume":"21","author":"Garmish O","year":"2025","unstructured":"Garmish O, Smiyan S, Hladkykh F, Koshak B, Komorovsky R. The effects of disease-modifying antirheumatic drugs on cardiovascular risk in inflammatory joint diseases: current evidence and uncertainties. Vasc Health Risk Manag. 2025, 21:593-605. 10.2147\/VHRM.S523939","journal-title":"Vasc Health Risk Manag"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13653","article-title":"Sulfasalazine exacerbates angiotensin II-induced cardiac remodelling by activating Akt signal pathway","volume":"49","author":"Chen C","year":"2022","unstructured":"Chen C, Zhang X, Zheng C, Gao Z, Jiang X, Bai Y, Meng Y. Sulfasalazine exacerbates angiotensin II-induced cardiac remodelling by activating Akt signal pathway. Clin Exp Pharmacol Physiol. 2022, 49:776-83. 10.1111\/1440-1681.13653","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2024.0104","article-title":"Risk of acute myocardial infarction associated with anti-rheumatic agents in patients with rheumatoid arthritis: a nationwide population-based case-control study","volume":"32","author":"Ahn SM","year":"2025","unstructured":"Ahn SM, Kim S, Kim YJ, et al.. Risk of acute myocardial infarction associated with anti-rheumatic agents in patients with rheumatoid arthritis: a nationwide population-based case-control study. J Rheum Dis. 2025, 32:113-21. 10.4078\/jrd.2024.0104","journal-title":"J Rheum Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.171023.rof","article-title":"Risk of major adverse cardiovascular events and venous thromboembolism with JAK inhibitors versus TNF inhibitors in rheumatoid arthritis patients: a systematic review and meta-analysis","volume":"35","author":"Partalidou S","year":"2024","unstructured":"Partalidou S, Patoulias D, Deuteraiou K, Avgerou P, Kitas G, Tzitiridou-Chatzopoulou M, Dimitroulas T. Risk of major adverse cardiovascular events and venous thromboembolism with JAK inhibitors versus TNF inhibitors in rheumatoid arthritis patients: a systematic review and meta-analysis. Mediterr J Rheumatol. 2024, 35:10-9. 10.31138\/mjr.171023.rof","journal-title":"Mediterr J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499260-in-hospital-complications-of-acute-decompensated-heart-failure-patients-with-comorbid-rheumatoid-arthritis-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:18:58Z","timestamp":1785111538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499260-in-hospital-complications-of-acute-decompensated-heart-failure-patients-with-comorbid-rheumatoid-arthritis-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.113417","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,26]]}}}